Humana participated in a series B round that boosted the kidney care provider's funding to $172m altogether.

The Tsinghua-backed DNA and RNA sequencing equipment manufacturer has added $63m to its coffers.

The at-home diagnostic services provider has passed $260m in overall funding through a series D round backed by Illumina Ventures and Optum Ventures.

Baidu Ventures has re-upped its commitment to the DNA and RNA sequencing equipment manufacturer, joining investors including Sunshine Insurance’s Riverhead Capital vehicle.

McCain helped meatless nugget producer Simulate secure a $250m valuation while retail technology developer Grabango raised $39m from investors including Unilever and Honeywell.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The SoftBank and Sinopharm-backed medicine delivery service will allocate the funding to diversifying its business, potentially adding teleconsultation, counselling and insurance.

Humana and Cox Enterprises are set to exit the primary care provider in an all-share acquisition by publicly listed peer One Medical.

Tata subsidiary Tata Digital Digital has hired CureFit’s CEO as part of a $75m investment round for the Unilever Ventures-backed health and fitness app developer.

Mayo Clinic returned to reinvest in the genomics platform developer three years after backing its series B round alongside Illumina.